STENOCARE expands in Australia
STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENO STENOCARE A/S (“Stenocare”) has entered into a new partnership agreement with Quest Biotech Pharma (“QBP”), aimed at expanding its reach to more prescribing doctors and patients in Australia. The agreement has the potential to double the sales run rate of Stenocare-branded products in Australia during 2024.Australia is an increasingly important market. Stenocare is a supplier of prescription-based medical cannabis oil products in various markets and has been present in the Australian market since Q4 2022. According